Patents Examined by Nelson Yang
-
Patent number: 7087203Abstract: This invention relates to clinical diagnostic assays and related optical bio-discs and a disc-reading apparatus. The invention is directed to a method for determining the blood cell type of an individual.Type: GrantFiled: November 19, 2001Date of Patent: August 8, 2006Assignees: Nagaoka & Co., Ltd., Burnstein Technologies, Inc.Inventors: John Francis Gordon, Susan Newcomb Hurt, David Samuel Cohen
-
Patent number: 7060447Abstract: Intracellular translocation of proteins, particularly protein kinase C (PKC) isoenzymes, provides a surrogate test system for determining toxicity of candidate compounds. The profile of translocation with respect to at least one and preferably two or more signal transduction proteins can be correlated with-that of known toxins. In addition, databases of such profiles with respect to toxins of various types provide a useful set of standards for evaluating toxicity of candidate compounds. Moreover, to the extent that a toxin's profile mimics that found in a diseased state, the toxin can be used to construct screens for compounds alleviating the disease.Type: GrantFiled: November 13, 2003Date of Patent: June 13, 2006Assignee: Trellis Bioscience, Inc.Inventor: Lawrence M. Kauvar
-
Patent number: 7026131Abstract: This invention relates to clinical diagnostic assays, related optical bio-discs, and a disc-reading apparatus. The invention is directed to methods and apparatuses for performing immunohematology assays using an optical bio-disc analysis system. The invention is further directed to an optical bio-disc for performing an immunohematologic assay including a substrate having encoded information associated therewith. The encoded information may be readable by a disc drive assembly to control rotation of the disc. The disc may also include at least one target zone or capture zone associated with the substrate. The target zone is disposed at a predetermined location relative to a center of the substrate. The disc further includes a plurality of capture antibodies immobilized within the target zone, a flow channel, fluidic circuit, or analysis chamber associated with the target zone, and an input site in fluid communication with the analysis chamber.Type: GrantFiled: November 15, 2002Date of Patent: April 11, 2006Assignees: Nagaoka & Co., Ltd., Burstein Technologies, Inc.Inventors: Susan Newcomb Hurt, John Francis Gordon, Kevin Robert McIntyre
-
Patent number: 7022517Abstract: A system for the rapid characterization of multi-analyte fluids, in one embodiment, includes a light source, a sensor array, and a detector. The sensor array is formed from a supporting member into which a plurality of cavities may be formed. A series of chemically sensitive particles are, in one embodiment positioned within the cavities. The particles may be configured to produce a signal when a receptor coupled to the particle interacts with the analyte. Using pattern recognition techniques, the analytes within a multi-analyte fluid may be characterized.Type: GrantFiled: July 14, 2000Date of Patent: April 4, 2006Assignee: Board of Regents, The University of Texas SystemInventors: John T. McDevitt, Eric V. Anslyn, Jason B. Shear, Dean P. Neikirk, Damon V. Borich
-
Patent number: 7014815Abstract: Design, manufacture and use of optical discs that permit the concurrent and discriminable acquisition of signals from both operational features and nonoperational features is presented. The disc geometries and tracking schemes permit such discs to be read in, and data encoded by nonoperational features reported by, standard (or minimally-modified), optical disc readers. Single data layer first and second surface discs are described, as are multiple data layer discs. Use of the disks in analyte-specific assay is presented.Type: GrantFiled: May 11, 1999Date of Patent: March 21, 2006Assignees: Burstein Technologies, Inc., Nagaoka & Co., Ltd.Inventors: Mark O. Worthington, Jorma Virtanen
-
Patent number: 7008794Abstract: A method and apparatus for assay of multiple analytes. The method uses a sensing element comprising a substrate upon which is arranged a multiplicity of recognition elements, such that each element is laid out in a predetermined pattern. Each pattern is unique in that it can give rise to a characteristic diffraction pattern in the assay. The patterns may or may not be interpenetrating on the substrate surface. The method of detecting multiple analytes includes contacting the medium of analytes with the patterned substrate, illuminating the substrate by a light source, and detecting any resultant diffraction image. The pattern of diffraction and the intensity of the diffracted signal provides information about the existence of specific analytes and their quantification.Type: GrantFiled: March 22, 2001Date of Patent: March 7, 2006Assignee: Axela Biosensors Inc.Inventors: M. Cynthia Goh, Jane B. Goh, Richard McAloney, Richard Loo
-
Patent number: 6974673Abstract: An evanescent-wave optical biosensor includes a hollow optical waveguide, preferably in the form of a light-conductive capillary, surrounding a central waveguide preferably in the form of an optical fiber to create a sealed cavity. A source of optical energy as from a laser is directed into one or both of the light-input ends of the capillary and fiber, such that an evanescent field extends into the cavity from one or both of the inner surface of the capillary and the outer surface of the fiber. A first biomolecular constituent is attached to one or both of the inner wall of the hollow optical waveguide and the outer surface of the second optical waveguide, such that the first biomolecular binding partner is substantially within the evanescent field if present.Type: GrantFiled: September 24, 2001Date of Patent: December 13, 2005Assignee: Veridian Systems DivisionInventor: Michael D. Lockhart
-
Patent number: 6949344Abstract: A method the direct analysis of an analyte in keratinized structures, e.g., hair and fingernails, which comprises preparing a mixture containing a low redox potential activator compound such as dithiothreitol or dithioerythritol, an enzyme suitable for the digestion of the keratin structure, a sample of the keratin structure and a biological detergent that aids the digestion of the keratinized structure at a relatively low pH, e.g., between about 6.2 and 8; permitting the enzyme to at least substantially digest the sample of keratin structure, and subjecting the digest solution to analysis, preferably by radioimmunoassay, to determine the identity and amount of analyte in the keratin structure sample. To accelerate the method, cupric sulfate may be added to the mixture after degradation of the keratin sample. The enzyme may be a peptidase, endopeptidase or proteinase, with papain, chymopapain, and proteinase K being preferred for use in the invention.Type: GrantFiled: July 30, 1991Date of Patent: September 27, 2005Assignee: Psychemical CorporationInventor: Werner Andreas Baumgartner
-
Patent number: 6924111Abstract: Provided is a microarray substrate. The microarray substrate includes a patterned photoresist film having one or more spot regions therein. The photoresist film can be detached from the substrate.Type: GrantFiled: January 20, 2004Date of Patent: August 2, 2005Assignee: Samsung Electronics Co., Ltd.Inventors: Soo-suk Lee, Sun-hee Kim, Young Choi
-
Patent number: 6897031Abstract: Described is a method for screening for alterations in exocytosis of a population of cells. The cells are sorted by a FACS machine by assaying for alterations in at least three of the properties selected from the group consisting of light scattering, fluorescent dye uptake, fluorescent dye release, annexin granule binding, surface granule enzyme activity, and the quantity of granule specific proteins. Methods for screening for bioactive agents capable of modulating exocytosis in a cell are also described. The methods provide for reduced background and increased specificity without increasing the time or steps involved in assaying for exocytosis.Type: GrantFiled: April 17, 1998Date of Patent: May 24, 2005Assignee: Rigel Pharmaceuticals, Inc.Inventors: Joseph Fisher, James Lorens, Donald Payan, Alexander Rossi
-
Patent number: 6861251Abstract: The present invention concerns methods and compositions relating to matrix arrays. In certain embodiments, the arrays are translucent. In other embodiments, the arrays are reconfigurable. In preferred embodiments, the arrays are translucent and reconfigurable. Reconfigurable arrays may be produced using small linker molecules, such as aptamers or affibodies, attached to the array substrate. Preferably, the small linker molecules bind to an IgG specific portion of antibodies. Such arrays may be used to detect any target that binds selectively or specifically to an IgG, allowing great flexibility of use. Translucent matrix arrays may utilize a translucent, colloidal form of nitrocellulose to coat the array substrate.Type: GrantFiled: February 24, 2003Date of Patent: March 1, 2005Assignee: PriTest, Inc.Inventor: Lawrence R. Green
-
Patent number: 6790632Abstract: A membrane receptor reagent and assay is disclosed in which liposomes are bound to an evanescent wave emitting surface. Membrane receptors on the liposome's fluid lipid bilayer membrane are labeled with a fluorescent or luminescent moiety. These membrane receptors are free to diffuse randomly throughout the liposome surface, and thus tend to redistribute according to externally applied forces. The evanescent wave-emitting surface additionally contains reagents that reversibly bind to the membrane receptors, tending to bring them closer to region of high evanescent wave intensity. Test analytes that disrupt or promote the association between the membrane receptors and the surface reagents act to change the average distance between the membrane receptors and the evanescent wave emitting surface, resulting in a change in the fluorescent or luminescent signal.Type: GrantFiled: May 23, 2003Date of Patent: September 14, 2004Inventor: Stephen Eliot Zweig